Skip to content
Research Article Open access CC BY 4.0

Evaluation of Oxidative Stress and DNA Damage in Acromegaly Patients in a Follow-up Study at a Public Tertiary Health Service

A. C. M. Bonini, C. D. L. Oliveira, L. C. Talon, D. T. Pierine, F. V. Francisqueti, C. R. Correa, V. S. Nunes-Nogueira

Asian Journal of Research and Reports in Endocrinology · pp. 12–20 · Published 28 May 2020

10.9734/ajrre/2020/v3i113

Abstract

We evaluated oxidative stress (OS) and DNA damage in acromegaly patients in a follow-up study at a public tertiary health service. Acromegaly patients in follow up at a public tertiary health service from 2012 to 2013 were enrolled in this study. Healthy volunteers were selected as control group. OS was evaluated in plasma and peripheral lymphocytes by determining total antioxidant capacity (TAP), lipophilic antioxidant levels and lipid peroxidation through malondialdehyde (MDA) levels. DNA damage was determined using the comet test. Fifteen acromegaly patients and 19 healthy individuals were included. Considering IGF1 levels<1.3´ the upper limit of the normal range as disease under control, 20% of individuals were uncontrolled for the disease. No significant difference in total carotenoid levels, TAP, or DNA damage was found between groups (respectively, 62.8 and 46, p=0.13; 51.3 and 43.5, p=0.093; 41.4.0 and 47.2, p=0.15). On the other hand, median MDA levels in the acromegaly group was significantly lower than that in the control group (0.44 and 0.977, respectively; p<0.001, Mann-Whitney test). A subgroup comparison within acromegaly patients revealed no statistically significant difference (p>0.05) between those with normal or increased IGF1 levels, with or without metabolic syndrome, or with or without use of statin (0.4 vs. 0.436, 0.42 vs. 0.5 and 0.533 vs, 0.413, respectively). Acromegaly patients when compared with a healthy control group did not present significantly higher levels of OS, antioxidants and DNA damage. However, most patients included in our study achieved disease control.

Acromegaly oxidative stress antioxidant DNA damage comet test

References (25)

  1. 1 A simple technique for quantitation of low levels of DNA damage in individual cells [DOI]
  2. 2 Biochemistry and molecular cell biology of diabetic complications [DOI]
  3. 3 Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing [DOI]
  4. 4 Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress [DOI]
  5. 5 AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept [DOI]
  6. 6 Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls [DOI]
  7. 7 Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma [DOI]
  8. 8 Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis [DOI]
  9. 9 Roles of Oxidative Stress and Redox Regulation in Atherosclerosis [DOI]
  10. 10 Measurement of carotenoids, retinoids, and tocopherols in human lenses.
  11. 11 A method to measure the oxidizability of both the aqueous and lipid compartments of plasma [DOI]
  12. 12 Total antioxidant performance: A validated fluorescence assay for the measurement of plasma oxidizability [DOI]
  13. 13 Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis [DOI]
  14. 14 Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study [DOI]
  15. 15 Octreotide improves reperfusion-induced oxidative injury in acute abdominal hypertension in rats [DOI]
  16. 16 Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats [DOI]
  17. 17 Vascular Function and Blood Pressure in GH Transgenic Mice [DOI]
  18. 18 Oxidative Stress and Reduced Antioxidative Status, along with Endothelial Dysfunction in Acromegaly [DOI]
  19. 19 Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly [DOI]
  20. 20 Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly [DOI]
  21. 21 Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans [DOI]
  22. 22 IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes [DOI]
  23. 23 Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice [DOI]
  24. 24 Endothelial dysfunction in growth hormone transgenic mice [DOI]
  25. 25 Mortality in Acromegaly: A metaanalysis [DOI]

Cited by 2

Synergistic effects of melatonin and zinc oxide nanoparticles on oxidative stress mitigation, nutrient accumulation, and secondary metabolite enhancement in Cannabis sativa L

Hakimeh Oloumi, Leila Malekpourzadeh, Zakiyeh Poursheikhali · Plant Nano Biology · 2025

Assessment of Malondialdehyde and Soluble α-Klotho Serum Levels in Iraqi Acromegaly Patients

Areej Sh. Hameed, Baydaa Ahmed Abed, Osama Abbas Mahdi · Iraqi Journal of Science · 2024

Related research

Article metrics

Real usage data collected on this platform.

56

Page views

0

PDF downloads

15

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.